| Capecitabine Accord 300 mg film-coated tablets EU/1/12/762/007-012 |
Capecitabine |
Accord Healthcare S.L.U. |
— |
| Capecitabine Accord 500 mg film-coated tablets EU/1/12/762/013-018 |
Capecitabine |
Accord Healthcare S.L.U. |
— |
| Capecitabine medac 150 mg film-coated tablets EU/1/12/802/001-014 |
Capecitabine |
medac Gesellschaft für klinische Spezialpräparate mbH |
— |
| Capecitabine medac 500 mg film-coated tablets EU/1/12/802/029-042 |
Capecitabine |
medac Gesellschaft für klinische Spezialpräparate mbH |
— |
| Capecitabine Teva 150 mg film-coated tablets EU/1/12/761/001 |
Capecitabine |
Teva B.V. |
— |
| Capecitabine Teva 500 mg film-coated tablets EU/1/12/761/002 |
Capecitabine |
Teva B.V. |
— |
| Caprelsa 100 mg film-coated tablets EU/1/11/749/001 |
Vandetanib |
Esteve Pharmaceuticals S.A. |
— |
| Caprelsa 300 mg film-coated tablets EU/1/11/749/002 |
Vandetanib |
Esteve Pharmaceuticals S.A. |
— |
| Caprin 75 mg gastro-resistant tablets PA0281/268/001 |
Acetylsalicylic acid |
Pinewood Laboratories Limited |
Marketed |
| CAPVAXIVE solution for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (21-valent) EU/1/25/1913/001-006 |
Pneumococcal Polysaccharide Serotype 3 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 6A Conjugated to CRM197, Pneumococcal polysaccharide serotype 7F conjugated to CRM197, Pneumococcal polysaccharide serotype 8 conjugated to CRM197, Pneumococcal polysaccharide serotype 9N conjugated to CRM197 |
Merck Sharp & Dohme BV, |
— |
| Carbaglu 200 mg dispersible tablets EU/1/02/246/1-2 |
Carglumic acid |
Recordati Rare Diseases |
— |
| Carbamazepine 100 mg Tablets PA22871/010/001 |
Carbamazepine |
Azure Pharmaceuticals Ltd. |
Not marketed |
| Carbamazepine 200 mg Tablets PA22871/010/002 |
Carbamazepine |
Azure Pharmaceuticals Ltd. |
Not marketed |
| Carbamazepine 400 mg Tablets PA22871/010/003 |
Carbamazepine |
Azure Pharmaceuticals Ltd. |
Not marketed |
| Carbamazepine Essential Pharma 125 mg Suppositories PA22644/003/001 |
Carbamazepine |
Essential Pharma (M) Limited |
Not marketed |
| Carbamazepine Essential Pharma 250 mg Suppositories PA22644/003/002 |
Carbamazepine |
Essential Pharma (M) Limited |
Not marketed |
| Carbidopa/Levodopa Fair-Med 10 mg/100 mg Tablets PA1789/007/002 |
Levodopa, Carbidopa monohydrate |
Fairmed Healthcare GmbH |
Not marketed |
| Carbidopa/Levodopa Fair-Med 12.5mg/50mg Tablets PA1789/007/001 |
Levodopa, Carbidopa monohydrate |
Fairmed Healthcare GmbH |
Not marketed |
| Carbidopa/Levodopa Fair-Med 25 mg/100 mg Tablets PA1789/007/003 |
Levodopa, Carbidopa monohydrate |
Fairmed Healthcare GmbH |
Not marketed |
| Carbidopa/Levodopa Fair-Med 25 mg/250 mg Tablets PA1789/007/004 |
Levodopa, Carbidopa monohydrate |
Fairmed Healthcare GmbH |
Not marketed |
| Carbimazole 20 mg Tablets PA2130/001/002 |
Carbimazole |
Essential-Healthcare Ltd. |
Not marketed |
| Carbimazole 20 mg Tablets PA22865/006/002 |
Carbimazole |
Renata Pharmaceuticals (Ireland) Limited |
Marketed |
| Carbimazole 5 mg Tablets PA2130/001/001 |
Carbimazole |
Essential-Healthcare Ltd. |
Not marketed |
| Carbimazole 5 mg Tablets PA22865/006/001 |
Carbimazole |
Renata Pharmaceuticals (Ireland) Limited |
Marketed |
| Carbomix 50 g Granules for Oral Suspension PA1418/007/001 |
Charcoal, activated |
Athlone Pharmaceuticals Limited |
Marketed |
| Carboplatin 10 mg/ml concentrate for solution for infusion PA2315/080/001 |
Carboplatin |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Carboplatin 10 mg/ml concentrate for solution for infusion PA2059/032/001 |
Carboplatin |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Carboplatin-Teva 10 mg/ml Concentrate for Solution for Infusion PA0749/004/001 |
Carboplatin |
Teva Pharma B.V. |
Marketed |
| Carbosan 2% w/w Gel PA0074/011/001 |
CARBENOXOLONE SODIUM |
Rowa Pharmaceuticals Limited |
Marketed |
| Carbosylane 140mg/45mg Capsules PA0345/001/001 |
Simeticone, Charcoal, activated |
Laboratoires Grimberg |
Marketed |
| Cardicor 1.25 mg film-coated tablets PA2286/004/001 |
Bisoprolol hemifumarate |
Merck Serono (Ireland) Limited |
Marketed |
| Cardicor 10 mg film-coated tablets PA2286/004/006 |
Bisoprolol hemifumarate |
Merck Serono (Ireland) Limited |
Marketed |
| Cardicor 2.5 mg film-coated tablets PA2286/004/002 |
Bisoprolol hemifumarate |
Merck Serono (Ireland) Limited |
Marketed |
| Cardicor 3.75 mg film-coated tablets PA2286/004/003 |
Bisoprolol hemifumarate |
Merck Serono (Ireland) Limited |
Marketed |
| Cardicor 5 mg film-coated tablets PA2286/004/004 |
Bisoprolol hemifumarate |
Merck Serono (Ireland) Limited |
Marketed |
| Cardicor 7.5 mg film-coated tablets PA2286/004/005 |
Bisoprolol hemifumarate |
Merck Serono (Ireland) Limited |
Marketed |
| CARDURA 1mg Tablets PA23355/003/001 |
Doxazosin mesilate |
Viatris Healthcare Limited |
Marketed |
| CARDURA 2mg Tablets PA23355/003/002 |
Doxazosin mesilate |
Viatris Healthcare Limited |
Marketed |
| Cardura XL 4 mg Prolonged-release tablets PA23355/001/001 |
Doxazosin mesilate |
Viatris Healthcare Limited |
Marketed |
| Cardura XL 8 mg Prolonged-release tablets PA23355/001/002 |
Doxazosin mesilate |
Viatris Healthcare Limited |
Marketed |
| Cariban 10 mg/10 mg modified-release hard capsules PA1776/002/001 |
DOXYLAMINE SUCCINATE, Pyridoxine hydrochloride |
Italfarmaco S.p.A. |
Marketed |
| Cariban 10 mg/10 mg modified-release hard capsules PPA2306/040/001 |
DOXYLAMINE SUCCINATE, Pyridoxine hydrochloride |
Originalis B.V. |
— |
| Carmustine 100 mg powder and solvent for concentrate for solution for infusion PA22720/003/001 |
Carmustine |
Tillomed Pharma GmbH |
Marketed |
| Carmustine 100 mg powder and solvent for concentrate for solution for infusion PA2315/239/001 |
Carmustine |
Accord Healthcare Ireland Ltd. |
Marketed |
| Carmustine 300 mg powder and solvent for concentrate for solution for infusion PA2315/250/002 |
Carmustine |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Carmustine 50 mg powder and solvent for concentrate for solution for infusion PA2315/250/001 |
Carmustine |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Carmustine medac 100 mg powder and solvent for concentrate for solution for infusion EU/1/18/1278/001 |
Carmustine |
medac Gesellschaft für klinische Spezialpräparate mbH |
— |
| Carnation Callous Caps 40% w/w Medicated plasters PA23188/001/002 |
Salicylic acid |
Cuxson Gerrard Healthcare Limited |
Marketed |
| Carnation Corn Caps 40% w/w Medicated plasters PA23188/001/001 |
Salicylic acid |
Cuxson Gerrard Healthcare Limited |
Marketed |
| Carnation Vericap Verruca Treatment 10% w/w medicated plaster PA23188/001/003 |
Salicylic acid |
Cuxson Gerrard Healthcare Limited |
Marketed |